-
Parkinson's Disease
-
Restless Leg Syndrome
- Symptoms for at least 2 days/week for 3 months
- Non-ergot selective Dopamine receptor Agonist
- Half life: 7-17 hours
- Minimal metabolism
- Unknown safety in pregnancy and Lactation
-
Nausea (common)
- Drowsiness (Limited to higher dosages)
- May be sudden, severe without warning
- May occur up to one year after starting Mirapex
- Has resulted in falling asleep while driving
- Augmentation of Restless Leg Symptoms
- Occurs in 25% of RLS patients on longterm therapy
- May progress in severity, and involve arms, trunk
- Often better if dose timing changed to earlier in day
- May be worse if dose increased
- Other uncommon adverse effects (rare at low dose)
- Hallucinations
- Pathologic Gambling (related to Dopamine receptor Agonist activity, D3)
- Orthostatic Hypotension
- Hypersexuality
- Immediate Release
- Start 0.125 mg three times daily for one week
- Next 0.25 mg three times daily
- May increase by 0.25 mg/dose each week as needed up to 4.5 mg/day
- Target 1.5 to 4.5 mg/day
- Renal adjustments
- GFR 30 to 50 ml/min: Start 0.125 mg orally twice daily (maximum 0.75 mg three times daily)
- GFR 15 to 30 ml/min: Start 0.125 mg orally daily (may increase 0.125 mg/dose/week, max: 1.5 mg daily)
- Extended Release
- Start 0.375 mg daily
- After 5 to 7 days, may increase by 0.75 mg/dose each week up to 4.5 mg/day
- Renal adjustments
- GFR 30 to 50 ml/min: May increase dose 0.375 mg/dose/week (max: 2.25 mg/day)
- Avoid extended release when GFR <30 ml/min
- Discontinuation (immediate or extended release)
- Reduce daily total dose by 0.75 mg/day until dose 0.75 mg/day
- Next reduce total dose by 0.35 mg/day
- Start: Mirapex 0.125 mg orally taken 2-3 hours before bedtime
- Interval for increasing dose if ineffective is based on Renal Function
- GFR >60 ml/min: Increase dose every 3-7 days
- GFR 20-60 ml/min: Increase dose every 14 days
- Titrating dose: Increase at set interval as above by one tablet if ineffective at current dose
- Start at 0.125 mg one tablet nightly for set interval in days
- Increase to two tablets (0.25 mg) nightly for set interval if ineffective at 0.125 mg
- Increase to three tablets (0.375 mg) nightly for set interval if ineffective at 0.25 mg
- Maximum dose: 6 tablets (0.75 mg) taken at bedtime
- Stopping: No titration needed
- At least 50% reduction in symptoms in 60% of patients
- Placebo had similar reduction in 42%
-
Number Needed to Treat: 6
- Symptoms recur when Mirapex is stopped
loading